DBV Technologies SA (DBVT)
20.59
-0.81
(-3.78%)
USD |
NASDAQ |
Apr 10, 16:00
20.65
+0.06
(+0.29%)
After-Hours: 20:00
DBV Technologies EPS Diluted (Quarterly) : -1.170 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| EDAP TMS SA | -0.2523 |
| Cellectis SA | -0.2621 |
| Ascendis Pharma A/S | -0.6364 |
| Akari Therapeutics Plc | 0.00 |
| Biodexa Pharmaceuticals Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.80M |
| Total Expenses (Quarterly) | 44.80M |
| Enterprise Value | 959.11M |
| Earnings Yield | -25.61% |
| Normalized Earnings Yield | -25.61 |